CA-ESRI
30.11.2021 14:03:00 CET | Business Wire | Press release
A new app that can manage conservation plans and verify corporate environmental promises with clear imagery from the sky is being powered in partnership with Esri and its ArcGIS Image for ArcGIS Online. The Ranger app from Skytec, a Chattanooga, Tennessee-based geospatial and remote sensing firm, uses aerial drones and satellite imagery to remotely monitor a subscriber's property from above.
Ranger provides notifications when changes emerge, without the costly expense and time spent for on-site monitoring. Observable changes to the land could include encroachment by others; deforestation; impending pest infestations; and other environmental concerns including natural and unnatural disasters such as floods, fires, and spills.
"ArcGIS Image for ArcGIS Online has given us more time to focus on what we do best—analysis—rather than having to stand up the infrastructure operating behind the scenes. With Esri, those secure back-end systems are built in," said Skytec Chief Technology Officer Andrew Carroll.
The technology from Redlands, California-based Esri, the global leader in location intelligence, processes and securely stores the imagery powering Skytec's Ranger app in the cloud.
"Being able to understand and accurately measure success is half the battle in conservation, and this app allows users to know the precise impact of their efforts," said Jack Dangermond, Esri founder and president. "Skytec created the kind of sustainable solution our world needs to solve urgent climate concerns, and we're pleased to partner in providing the tools to help the firm grow."
Through Ranger, customers can choose how frequently they receive timed reports showing activity and highlighting changes on the areas they want monitored. If customers want more information about a change event, they can order higher-resolution satellite or drone imagery captured with lidar or send their own staff to observe in person. Those choices are then coordinated through Esri's ArcGIS Survey123 application.
Ranger is already monitoring more than 100,000 acres across the country with help from ArcGIS Image for ArcGIS Online. Among its clients are the Palmer Land Conservancy and the Hudson Highlands Land Trust.
Skytec CEO Bill Rogers and Carroll started the company as commercial drone operations began to take off, by monitoring small sites with unmanned aerial vehicles before expanding to include piloted flight observations. Now, with satellite imagery from Planet, Skytec wants Ranger to be a global solution to climate change by providing macro views of land showing if conservation strategies are working.
"We're anticipating clients' needs for seamless monitoring at any level of any location around the globe," Rogers said. "This service is beneficial for clients in a variety of industries, from natural resource management to environmental mitigation firms and utilities."
The application also has the potential to prove an entity has kept its environmental promises.
"There's an opportunity to begin to come in and fill the data science needs that are behind corporate sustainability initiatives," Carroll said. Monitoring can show where mitigation measures have been made, where growth has occurred, and what, if any, recovery has been achieved. It can also monitor for carbon offsets and ecological ecosystem banking.
"Everyone's talking a great talk, but where's the data behind it," Carroll said of what Ranger provides.
The Ranger application, built with Esri's ArcGIS Web AppBuilder, is optimized for desktop and tablet use. The partnership with Esri also gives Skytec and its Ranger customers access to the mapping leader's extensive library of online data, including its ArcGIS Living Atlas of the World, and a seamless experience for existing Esri users.
To learn how Esri can help businesses more easily access, process, and manage imagery in the cloud, visit go.esri.com/arcgisimage .
About Esri
Esri, the global market leader in geographic information system (GIS) software, location intelligence, and mapping, helps customers unlock the full potential of data to improve operational and business results. Founded in 1969 in Redlands, California, USA, Esri software is deployed in more than 350,000 organizations globally and in over 200,000 institutions in the Americas, Asia and the Pacific, Europe, Africa, and the Middle East, including Fortune 500 companies, government agencies, nonprofits, and universities. Esri has regional offices, international distributors, and partners providing local support in over 100 countries on six continents. With its pioneering commitment to geospatial information technology, Esri engineers the most innovative solutions for digital transformation, the Internet of Things (IoT), and advanced analytics. Visit us at esri.com .
Copyright © 2021 Esri. All rights reserved. Esri, the Esri globe logo, ArcGIS, The Science of Where, esri.com, and @esri.com are trademarks, service marks, or registered marks of Esri in the United States, the European Community, or certain other jurisdictions. Other companies and products or services mentioned herein may be trademarks, service marks, or registered marks of their respective mark owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211130005341/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations30.4.2026 14:05:00 CEST | Press release
Significant unmet need remains for 85% of lupus patients whose disease includes skin manifestations, often associated with substantial physical and psychosocial burdenEnpatoran, an oral TLR7/8 inhibitor, is designed for lupus patients with active cutaneous manifestations, with the goal of broadening the treatment paradigm beyond the current standardsELOWEN is a global Phase 3 program evaluating enpatoran’s impact on both skin and systemic symptoms in patients with lupus and potential links between skin and systemic disease activity Merck, a leading global science and technology company, today announced the first patient was dosed in the Phase 3 program, ELOWEN-1 (NCT07332481) and ELOWEN-2 (NCT07355218), evaluating enpatoran in people living with lupus who experience active skin manifestations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430733656/en/ David Weinreich, Global Head of R&D and Chief Medical Officer “People
Riskified Announces 2026 Titans of Ecommerce Award Winners30.4.2026 14:00:00 CEST | Press release
Celebrating the ecommerce leaders from Michael Kors and Gymshark shaping the future of fraud prevention and risk management Riskified (NYSE: RSKD), a global leader in ecommerce fraud and risk intelligence, today announced the 2026 Titans of Ecommerce Awards, recognizing outstanding ecommerce leaders who are redefining fraud prevention while driving business growth. The winners are:Titan of Americas: Joseph Chin, Senior Director of Revenue Assurance, Michael Kors Joseph Chin has evolved revenue assurance into a strategic lever for growth at Michael Kors. Deeply knowledgeable in fraud and payments, he maintains a hands-on approach, continually collaborating with Riskified to identify innovative opportunities, optimize performance, and pilot new initiatives. Joseph is highly effective at building internal alignment and securing stakeholder buy-in for new strategies. His leadership shone during Cyber Five, where his close collaboration with Riskified and real-time insights delivered one of
The LYCRA Company Strengthens Sustainability Leadership, Appoints Alistair Williamson as VP of Product Sustainability30.4.2026 14:00:00 CEST | Press release
The LYCRA Company has appointed longtime executive Alistair Williamson as vice president of product sustainability, reaffirming its commitment to developing sustainable solutions for apparel and personal care products. In this role, he will guide the company’s next chapter of sustainability strategy and oversee all initiatives aimed at reducing environmental impact across products, operations, and innovation platforms. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430942396/en/ The LYCRA Company has appointed longtime executive Alistair Williamson as vice president of product sustainability, reaffirming its commitment to developing sustainable solutions for apparel and personal care products. Williamson has four decades of experience in textile fibers and apparel, having held commercial, sales, and marketing leadership roles across EMEA, North America, and South Asia. Before joining the predecessor of The LYCRA Company i
CorFlow Therapeutics Announces Successful Completion of Phase 1 and First Patients Enrolled in Phase 2 of the MOCA II Pivotal Trial, Approval to Start the REVITALISE RCT in Europe, and Strengthening of Clinical Leadership30.4.2026 13:00:00 CEST | Press release
Milestones advance clinical progress and path to commercialization CorFlow Therapeutics AG (CorFlow), a clinical-stage company focused on transforming the diagnosis and treatment for heart attack patients, today announced multiple milestones in advancing its clinical program and the strengthening of clinical leadership. Phase 1 of the company’s MOCA II FDA Pivotal Trial was successfully reached after safety and performance goals were met with STEMI heart attack patients who had the proprietary PCoFI diagnostic measurement of microvascular obstruction (MVO) made during a stenting procedure, when compared to the reference standard diagnosis by cardiac MRI in the subsequent days. Phase 1 included 19 patients enrolled across 5 US and 3 European sites. MOCA II follows the FIH MOCA I study and primarily aims to validate the threshold value of the proprietary PCoFI measurement for diagnosing MVO in the setting of primary angioplasty compared to cardiac MRI. This milestone achievement, which w
Agendia to Present New Data Demonstrating the Expanded Clinical Utility of MammaPrint® and BluePrint® at the 2026 ESMO Breast Cancer Annual Congress30.4.2026 13:00:00 CEST | Press release
Poster presentations highlight the prognostic value of MammaPrint + Blueprint in small, node-negative tumors and impact of BMI on recurrence dynamics Agendia®, Inc., a leader in precision oncology for breast cancer, today announced it will present new data at the 2026 European Society for Medical Oncology (ESMO) Annual Congress on Breast Cancer, taking place May 6-8 in Berlin, Germany. The company will present two posters featuring data from the prospective FLEX Study and an independent post hoc analysis of the landmark MINDACT trial that underscore the prognostic value of MammaPrint® + BluePrint® in early-stage breast cancer (EBC). Poster #65P | Thursday, May 7, 13:15 – 14:15 p.m. CEST | Presenter: Elena Shagisultanova Prognostic Performance of MammaPrint in Patients with Small T1a, b, and c Node-Negative Early Breast Cancer A retrospective analysis from the FLEX Study involving 4,349 patients highlights the biological heterogeneity within small, node-negative (T1a, b, and c) tumors –
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
